ArticleCancer immunology, immunotherapy : CII2012

CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy.

Sivan Sapoznik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.